Debasish Panda, chairman, IRDAI The regulatory body's chief said...
Category:
Non-Life
Latest
GST on term life insurance premium, senior citizens’ health cover likely to be exempted
The GoM to decide on the GST rate on life and health insurance met...
AXA Insurance announces strategic name change of “XL Re China” to “AXA International Re”
By leveraging data, pricing strategies, and market expertise, AXA...
India approves Zydus Cadila’s ZyCoV-D vaccine for emergency use for adults and children above 12 yrs
Chairperson of the Zydus Group, Pankaj R Patel said, “We are extremely happy that our efforts to put out a safe, well-tolerated and efficacious vaccine to fight COVID-19 has become a reality with ZyCoV-D. To create the world’s first DNA vaccine at such a crucial juncture and despite all the challenges, is a tribute to the Indian research scientists and their spirit of innovation. I’d like to thank the Department of Biotechnology under the Government of India for their support in this mission of Atma Nirbhar Bharat and Indian Vaccine Mission COVID Suraksha.”
Tokio Marine Insurance hit by ransomware attack in Singapore
“At this time, we can confirm that there is no indication of a breach of any customer information nor confidential information of the group, We have appointed an external specialized vendor to perform a third-party analysis of the systems to verify scope of impact,”” said the group in the statement.
UK court sets scene for $14 bln-plus class action against MastercardL
Merricks alleges Mastercard charged excessive “interchange” fees – the fees retailers pay credit card companies when consumers use a card to shop – between May 1992 and June 2008 and that those fees were passed on to consumers as retailers raised prices.
Report about fake Covishield vaccine being probed: Mandaviya
”It has been claimed that duplicate versions of Covishield vaccine were sold in the country. The Indian government is probing this claim, and will take action if it found any substance to the allegations,” he told reporters in Rajkot.
Ayushman Bharat: Over 0.7 mn Covid treatments authorised from Apr’20-Jul’21
“Under the Ayushman Bharat health insurance scheme, over 20 lakh tests and 7.25 lakh COVID-19 related treatments worth over Rs 2,800 crore were authorised from April 2020 to July 2021.The insurance scheme allows the beneficiaries to avail free testing and treatment across all empanelled — both public and private — hospitals,” an official said.
Karnataka cabinet approves implementation of Mental Healthcare Act for covid
Under the act, a State Mental Health Authority will be set up. A committee under the chairmanship of the Director of the NIMHANS Institute will be constituted for the drafting of guidelines for the authority. The authority will also maintain a registry and publish a list of clinical psychologists, nurses, social workers and health workers in the field of mental health.
The state act is being implemented in tandem with the Central Mental Healthcare Act, 2017.
Extreme heat growing health issue; killed 356,000 people in 2019: Study
“The effects extreme heat exposure can have on the body present a clear and growing global health issue,” said Ollie Jay, a professor from the University of Sydney, and a co-author of the Heat and Health report.
The findings echo another report, a two-part series called “Heat and Health” that was also published in The Lancet this week. It calls for global warming to be limited to 2.7 degrees F, in line with the Paris Climate Accords, to reduce heat-related mortality in the future. Otherwise, deaths will increase further and extreme heat will also lessen worker productivity and exacerbate other environmental challenges, such as wildfires, researchers said.
Over 3.86 crore people didn”t get 2nd dose of Covid vaccines within stipulated time: Govt
According to information on the CoWIN portal, as of Thursday afternoon 44,22,85,854 people have received their first dose, while 12,59,07,443 have also taken their second.
Indian states preparing for next COVID wave focus on children
As of March 2021, less than 1 pct of India’s coronavirus deaths were in the under 15 age group, according to the health ministry, and officials say the severity of the disease in this age group has been minimal so far.India provides vaccines to people above the age 18. Most vaccines administered in India are made by AstraZeneca Plc, while shots produced by local manufacturer Bharat Biotech are also being used.
Pfizer, AstraZeneca vaccines less effective against Delta variant: Study
The researchers, however, noted that with Delta, Pfizer-BioNTech vaccine and Oxford-AstraZeneca preventive, known as Covishield in India, still offer good protection against new infections.
Two doses of either vaccine still provided at least the same level of protection as having had COVID-19 before through natural infection, they said.